We are live on ! Find out more
WVE icon

Wave Life Sciences
WVE

78 hedge funds and large institutions have $936M invested in Wave Life Sciences in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 40 increasing their positions, 20 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 20

0.5% less ownership

Funds ownership: 84.54% → 84.04% (-0.5%)

1% less capital invested

Capital invested by funds: $949M → $936M (-$13.1M)

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

1% less funds holding

Funds holding: 79 → 78 (-1)

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

Holders
78
Holders Change
-1
Holders Change %
-1.27%
% of All Funds
1.79%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
11
Increased
40
Reduced
20
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$15.2M
2
BlackRock
BlackRock
New York
+$14M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$13.2M
4
BB
BB Biotech
Switzerland
+$10.4M
5
BC
Boxer Capital
California
+$10.4M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$45M
2
PA
Perceptive Advisors
New York
-$7.75M
3
DM
Deerfield Management
New York
-$3.85M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.28M
5
DCM
Driehaus Capital Management
Illinois
-$2.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
26
Allianz Asset Management
Germany
$5.12M +$5.76M +133,863 New
CCP
27
Clough Capital Partners
Massachusetts
$4.98M +$529K +12,300 +10%
WM
28
WS Management
Florida
$4.28M +$4.82M +112,000 New
Deutsche Bank
29
Deutsche Bank
Germany
$4.13M +$1.86M +43,224 +67%
AG
30
Artal Group
Luxembourg
$3.83M -$2.15M -50,000 -33%
Charles Schwab
31
Charles Schwab
California
$3.19M +$629K +14,615 +21%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$2.98M +$901K +20,920 +37%
FCMI
33
Foresite Capital Management III
California
$2.87M – – –
Bank of New York Mellon
34
Bank of New York Mellon
New York
$2.65M -$448K -10,417 -13%
EU
35
Emory University
Georgia
$2.6M +$863K +20,039 +42%
DCM
36
DAFNA Capital Management
California
$1.83M +$151K +3,500 +8%
Morgan Stanley
37
Morgan Stanley
New York
$1.49M +$514K +11,946 +44%
PP
38
PDT Partners
New York
$1.45M -$302K -7,008 -16%
MC
39
Matisse Capital
Oregon
$1.42M +$51.7K +1,200 +3%
TCIM
40
TIAA CREF Investment Management
New York
$1.36M +$244K +5,657 +19%
PIM
41
Platinum Investment Management
Australia
$1.23M – – –
SSA
42
Schonfeld Strategic Advisors
New York
$1.15M -$437K -10,163 -25%
TA
43
Teachers Advisors
New York
$1.11M +$323K +7,510 +35%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$1.03M +$385K +8,941 +50%
B
45
Bailard
California
$1.02M -$1.12M -26,000 -49%
PPA
46
Parametric Portfolio Associates
Washington
$946K -$1.03M -23,811 -49%
Goldman Sachs
47
Goldman Sachs
New York
$931K +$771K +17,921 +279%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$750K +$297K +6,900 +54%
Swiss National Bank
49
Swiss National Bank
Switzerland
$742K – – –
AllianceBernstein
50
AllianceBernstein
Tennessee
$715K +$168K +3,900 +26%
1
2
3 4

WVE Hedge Fund Activity: Q2 2018 in Review

78 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2018, worth a combined $936M — down 1.4% from $949M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of WVE and 11 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 40 added.

The largest buyer was Wells Fargo, adding an estimated $15.2M. The largest seller was EcoR1 Capital, cutting an estimated $45M.

  • 78 institutional investors held Wave Life Sciences (WVE) as of Q2 2018, down from 79 in Q1 2018.
  • Funds reported $936M of Wave Life Sciences stock for Q2 2018, down 1.4% quarter-over-quarter.
  • 11 funds opened new Wave Life Sciences positions in Q2 2018 and 12 closed out, a net change of -1 holder.
  • The largest Wave Life Sciences buyer in Q2 2018 was Wells Fargo, an estimated $15.2M added.
  • The largest Wave Life Sciences seller in Q2 2018 was EcoR1 Capital, an estimated $45M sold.

Based on aggregated 13F filings for Q2 2018.